Zuyu Liang

No.79 Qingchun Road
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

TNFAIP3 Overexpression Inhibits Diffuse Large B-Cell Lymphoma Progression by Promoting Autophagy through TLR4/MyD88/NF-κB Signaling Pathway.

TNFAIP3 Overexpression Inhibits Diffuse Large B-Cell Lymphoma Progression by Promoting Autophagy through TLR4/MyD88/NF-κB Signaling Pathway.

Journal: Discovery medicine
Published: August 27, 2024

MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-Fos and JunB.

MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-Fos and JunB.

Journal: Signal transduction and targeted therapy
Published: November 27, 2023

Efficacy of azithromycin in treating Ureaplasma urealyticum: a systematic review and meta-analysis.

Efficacy of azithromycin in treating Ureaplasma urealyticum: a systematic review and meta-analysis.

Journal: BMC infectious diseases
Published: December 30, 2022

Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction.

Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction.

Journal: Leukemia
Published: February 18, 2022

Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion.

Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion.

Journal: Journal of hematology & oncology
Published: April 29, 2021

Lymphodepletion chemotherapy revitalizes chimeric antigen receptor T cells contributing to regression of relapsed B-cell lymphoma: A case report.

Lymphodepletion chemotherapy revitalizes chimeric antigen receptor T cells contributing to regression of relapsed B-cell lymphoma: A case report.

Journal: Medicine
Published: October 30, 2020

Successful treatment of relapsed acute B-cell lymphoblastic leukemia with CD20/CD22 bispecific chimeric antigen receptor T-cell therapy.

Successful treatment of relapsed acute B-cell lymphoblastic leukemia with CD20/CD22 bispecific chimeric antigen receptor T-cell therapy.

Journal: Regenerative therapy
Published: September 28, 2020

Correction to: KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer.

Correction to: KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer.

Journal: Molecular cancer
Published: November 20, 2019

Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapy.

Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapy.

Journal: Bone marrow transplantation
Published: November 13, 2018

Interleukin-6 signaling regulates hematopoietic stem cell emergence.

Interleukin-6 signaling regulates hematopoietic stem cell emergence.

Journal: Experimental & molecular medicine
Published: August 04, 2018

The effectiveness of interferon-α combined with imatinib in patient with chronic myeloid leukemia harboring T315I BCR-ABL1 mutation.

The effectiveness of interferon-α combined with imatinib in patient with chronic myeloid leukemia harboring T315I BCR-ABL1 mutation.

Journal: Leukemia & lymphoma
Published: April 05, 2018

Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia.

Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 22, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026